Sign in
4

Changes in Ownership

Cardiff Oncology, Inc. Filed Acc 0001393415-26-000002

Options or other derivatives

  • Director acquired 40,565 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Markin Rodney S Director 2026-06-11 Grant or award · Stock Options +40,565 263,430 D: show line 1 in the form
Loading xslF345X06/ownership.xml…